Compare TBBK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBBK | VCYT |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | 733 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.8B |
| IPO Year | 2005 | 2013 |
| Metric | TBBK | VCYT |
|---|---|---|
| Price | $53.55 | $32.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $69.00 | $45.13 |
| AVG Volume (30 Days) | 477.7K | ★ 794.2K |
| Earning Date | 04-30-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.69 | ★ 164.52 |
| EPS | ★ 4.92 | 0.82 |
| Revenue | ★ $141,147,000.00 | N/A |
| Revenue This Year | N/A | $13.33 |
| Revenue Next Year | $11.90 | $12.53 |
| P/E Ratio | ★ $10.82 | $37.71 |
| Revenue Growth | ★ 20.85 | N/A |
| 52 Week Low | $40.51 | $22.61 |
| 52 Week High | $81.65 | $50.71 |
| Indicator | TBBK | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 36.04 |
| Support Level | $49.11 | $25.95 |
| Resistance Level | $53.83 | $32.79 |
| Average True Range (ATR) | 2.28 | 1.47 |
| MACD | 0.18 | -0.28 |
| Stochastic Oscillator | 38.54 | 15.82 |
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.